-transparent.png){kind=logo}
Sixteen patients with advanced head and neck carcinomas were treated with cis-diaminedichloro platinum chemotherapy; seven preoperatively and nine for recurrent disease. Cis-platinum was given by 24-hour infusions of 80 mg/m2 every three weeks. There was 50% regression in 38% (6) of the patients; another 38% (6) had 25% to 50% regression. Toxicity was minimal, with vomiting occurring in 75% (12) of the courses, renal toxicity in 6% (2), leukopenia in 13% (4), thrombocytopenia in 9% (3), and anemia in 31% (10). Of the seven patients who had serial audiograms, only one experienced ototoxicity. Cis-platinum, given by 24-hour infusion, was effective in reducing tumor bulk in 75% (12) of the patients, with advanced head and neck carcinomas, without undue morbidity.
C Jacobs, and
J R Bertino, and
D R Goffinet, and
W E Fee, and
R L Goode
October 1985,
Nihon Gan Chiryo Gakkai shi,
C Jacobs, and
J R Bertino, and
D R Goffinet, and
W E Fee, and
R L Goode
October 1980,
American journal of surgery,
C Jacobs, and
J R Bertino, and
D R Goffinet, and
W E Fee, and
R L Goode
January 1996,
Neoplasma,
C Jacobs, and
J R Bertino, and
D R Goffinet, and
W E Fee, and
R L Goode
February 1988,
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,
C Jacobs, and
J R Bertino, and
D R Goffinet, and
W E Fee, and
R L Goode
January 1982,
Head & neck surgery,
C Jacobs, and
J R Bertino, and
D R Goffinet, and
W E Fee, and
R L Goode
August 1982,
Gan to kagaku ryoho. Cancer & chemotherapy,
C Jacobs, and
J R Bertino, and
D R Goffinet, and
W E Fee, and
R L Goode
January 1981,
Archives of oto-rhino-laryngology,
C Jacobs, and
J R Bertino, and
D R Goffinet, and
W E Fee, and
R L Goode
July 1979,
Cancer,
C Jacobs, and
J R Bertino, and
D R Goffinet, and
W E Fee, and
R L Goode
May 2017,
Head & neck,
C Jacobs, and
J R Bertino, and
D R Goffinet, and
W E Fee, and
R L Goode
November 2005,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
